Augmedix, Inc. to Ring Nasdaq Closing Bell Today

Rhea-AI Summary

Augmedix recently celebrated its successful uplisting to Nasdaq under the ticker AUGX, marking a significant milestone for the company. CEO Manny Krakaris, accompanied by the Augmedix team and shareholders, rang the closing bell at Nasdaq MarketSite in New York's Times Square. The uplisting is seen as a critical step in Augmedix's mission to lead in virtual medical documentation through its Ambient Automation Platform, designed to alleviate documentation burdens on healthcare providers. The platform aims to enhance productivity and improve patient care.

Positive

• Successful uplisting to Nasdaq enhances credibility and market visibility.
• CEO's public engagement at Nasdaq may boost investor confidence.
• The Ambient Automation Platform aims to save physicians up to 3 hours a day and improve productivity by 20%.

Negative

• None.

Augmedix celebrates successful uplisting to Nasdaq and public offering

NEW YORK, Dec. 03, 2021 (GLOBE NEWSWIRE) -- AUGMEDIX, Inc. (NASDAQ: AUGX) (“Augmedix” or the “Company”), a leading digital health platform that offers virtual medical documentation and live clinical support, announced today Manny Krakaris, Chief Executive Officer of Augmedix, will ring the closing bell, together with the Augmedix team and shareholders, at Nasdaq MarketSite in New York’s Times Square this afternoon at approximately 4:00 p.m. Eastern Time, in celebration of Augmedix’s uplisting on the Nasdaq.

The ceremony will begin at approximately 3:45 p.m. Eastern Time and can be viewed live here.

“Our recent uplisting marked an important milestone in the evolution of our company, and we want to thank the Augmedix team for their unwavering commitment to our mission. It is an honor to be ringing the Nasdaq closing bell on behalf of this team to commemorate this achievement,” said Mr. Krakaris. “As we continue to execute and deliver on our initiatives, our objective is to be the leader in virtual documentation with our Ambient Automation Platform and to deliver our transformative solution to enable relief and support to doctors from immense documentation burden and to effect better patient care as a result.”

About Augmedix
Augmedix, Inc. (Nasdaq: AUGX) is a leading digital health platform that offers virtual medical documentation and live clinical support to large healthcare systems and physician practices, supporting medical offices, clinics, hospitals, emergency departments and telemedicine practices nationwide. The Company’s Ambient Automation Platform converts the natural conversation between physicians and patients into timely and comprehensive medical notes and provides a suite of related services. The medical note is generated using Augmedix’s proprietary platform, which incorporates structured data models, automatic speech recognition and natural language processing and is overseen by trained medical documentation specialists. Augmedix saves physicians up to 3 hours per day, improves productivity by as much as 20%, and increases satisfaction with work-life balance by over 40%. To learn more about Augmedix visit augmedix.com.

Investors:
Caroline Paul
Gilmartin Group
investors@augmedix.com

Media:
Kaila Grafeman
Augmedix
pr@augmedix.com

 

FAQ

What is Augmedix's recent achievement regarding Nasdaq and stock symbol AUGX?

Augmedix successfully uplisted to Nasdaq under the ticker symbol AUGX.

Who rang the closing bell at Nasdaq for Augmedix?

CEO Manny Krakaris rang the closing bell at Nasdaq to celebrate Augmedix's uplisting.

What is Augmedix's Ambient Automation Platform?

The Ambient Automation Platform by Augmedix converts physician-patient conversations into comprehensive medical notes, aiming to reduce documentation burden.

What benefits does Augmedix's platform provide to healthcare providers?

Augmedix's platform can save physicians up to 3 hours per day and improve work-life satisfaction by over 40%.